DnB Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
27,754
-102
| -0.4% | -$378 | ﹤0.01% | 709 |
|
|
2025
Q1 | $90K | Buy |
27,856
+11,558
| +71% | +$37.3K | ﹤0.01% | 722 |
|
|
2024
Q4 | $90.8K | Sell |
16,298
-9,390
| -37% | -$52.3K | ﹤0.01% | 722 |
|
|
2024
Q3 | $278K | Buy |
+25,688
| New | +$278K | ﹤0.01% | 682 |
|
|
2024
Q2 | – | Sell |
-7,363
| Closed | -$234K | – | 714 |
|
|
2024
Q1 | $234K | Buy |
+7,363
| New | +$234K | ﹤0.01% | 688 |
|